FULC · Healthcare · $283M
$3.70+0.09%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 463 Biotechnology peers
“이번 분기 가장 큰 뉴스는 '포시레디르'라는 신약 후보물질의 임상 1b상(PIONEER 시험) 결과예요.”
In the company's words · 2026 1분기 earnings call